{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:27Z","timestamp":1759333647198,"version":"3.44.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.pcl.2009.12.003","type":"journal-article","created":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T04:13:06Z","timestamp":1269144786000},"page":"239-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease"],"prefix":"10.1016","volume":"57","author":[{"given":"Francesca","family":"Milanetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Abinun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C.","family":"Voltarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pcl.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.22256","article-title":"Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens","volume":"54","author":"Burt","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pcl.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib3","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pcl.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0609.2005.00569.x","article-title":"Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation","volume":"76","author":"Fr\u00e8re","year":"2006","journal-title":"Eur J Haematol"},{"issue":"9563","key":"10.1016\/j.pcl.2009.12.003_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2009.12.003_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-6-11","article-title":"A comprehensive review of the genetics of juvenile idiopathic arthritis","volume":"6","author":"Prahalad","year":"2008","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/rheumatology\/kep125","article-title":"Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis","volume":"48","author":"Van den Ham","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.pcl.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","article-title":"Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis","volume":"60","author":"Barnes","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4CD25 immune regulatory network","volume":"107","author":"De Kleer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2009.12.003_bib11","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4CD25Foxp3 regulatory T cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1542\/peds.109.1.109","article-title":"Current treatment of juvenile rheumatoid arthritis","volume":"109","author":"Ilowite","year":"2002","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.pcl.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","article-title":"Medical treatment of juvenile idiopathic arthritis","volume":"294","author":"Haskes","year":"2005","journal-title":"JAMA"},{"issue":"9152","key":"10.1016\/j.pcl.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)05399-9","article-title":"Autologous haemopoietic stem cell transplantation in four patients with refractory juvenile chronic arthritis","volume":"353","author":"Wulffraat","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/rheumatology\/38.8.737","article-title":"Autologous stem cell transplantation: an alternative for refractory juvenile chronic arthritis","volume":"38","author":"Kuis","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/38.8.777","article-title":"Proposed guidelines for autologous stem cell transplantation in juvenile chronic arthritis (Addendum). Pediatric Rheumatology Workshop","volume":"38","author":"Wulffraat","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib17","first-page":"929","article-title":"Treatment of refractory juvenile idiopathic arthritis","volume":"28","author":"Wulffraat","year":"2001","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib18","first-page":"2337","article-title":"Autologous stem cell transplantation for pediatric rheumatic diseases. NIH Workshop Report","volume":"28","author":"Barron","year":"2001","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2009.12.003_bib19","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1038\/sj.bmt.1703946","article-title":"Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis","volume":"32","author":"Wulffraat","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2009.12.003_bib20","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.bmt.1704840","article-title":"Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis","volume":"35","author":"Wulffraat","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/adc.88.3.201","article-title":"Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis","volume":"88","author":"Wedderburn","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pcl.2009.12.003_bib22","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kel319a","article-title":"Autologous haematopoietic stem cell rescue for severe rheumatic disease in children","volume":"45","author":"Foster","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.pcl.2009.12.003_bib23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"Suppl\u00a01","key":"10.1016\/j.pcl.2009.12.003_bib24","first-page":"11","article-title":"Long term molecular follow up of immune repertoire after severe immunosuppression and autologous stem cell rescue in children with juvenile idiopathic arthritis [abstract]","volume":"42","author":"Wedderburn","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.pcl.2009.12.003_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","article-title":"Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines","volume":"27","author":"Brinkman","year":"2007","journal-title":"J clin Immunol"},{"key":"10.1016\/j.pcl.2009.12.003_bib26","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis. Long-term follow up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08916930802200224","article-title":"Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis","volume":"41","author":"Wulffraat","year":"2008","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","article-title":"Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000\u20132007)","volume":"47","author":"Abinun","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pcl.2009.12.003_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature03728","article-title":"Treatment of severe autoimmune disease by stem cell transplantation","volume":"435","author":"Sykes","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/bmt.2008.171","article-title":"Exercise tolerance in children with juvenile idiopathic arthritis after autologous SCT","volume":"42","author":"Takken","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pcl.2009.12.003_bib31","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(05)75094-7","article-title":"Haemopoietic stem cell transplantation for juvenile chronic arthritis","volume":"353","author":"Quartier","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bmt.1702781","article-title":"Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis","volume":"27","author":"Nakagawa","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02983820","article-title":"Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis","volume":"78","author":"Kishimoto","year":"2003","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2009.12.003_bib34","first-page":"81","article-title":"Infection associated MAS in 3 patients receiving ASCT for refractory juvenile chronic arthritis","volume":"25","author":"Vieger","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pcl.2009.12.003_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00431-002-1092-8","article-title":"Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis","volume":"161","author":"Ten Kate","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2009.12.003_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1705305","article-title":"Macrophage activation syndrome and other systemic inflammatory conditions after BMT","volume":"37","author":"Sreedharan","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bmt.1705415","article-title":"Hemophagocytosis during fludarabine-based SCT for systemic juvenile arthritis","volume":"38","author":"Ferreira","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pcl.2009.12.003_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0889-857X(02)00015-7","article-title":"Systemic lupus erythematosus in childhood","volume":"28","author":"Klein-Gitelman","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib39","first-page":"1650","article-title":"Gender and ethnic origin have no effect on long-term outcome of childhood onset systemic lupus erythematosus","volume":"31","author":"Miettunen","year":"2004","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2009.12.003_bib40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","article-title":"Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome","volume":"34","author":"Tucker","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.10072","article-title":"Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage","volume":"46","author":"Brunner","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.23204","article-title":"Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus","volume":"58","author":"Brunner","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0961203307087875","article-title":"Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)","volume":"17","author":"Tucker","year":"2008","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.24091","article-title":"Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus","volume":"61","author":"Hersh","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0961203307080636","article-title":"Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes","volume":"16","author":"Pluchinotta","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.pcl.2009.12.003_bib46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.bor.0000169364.69066.1e","article-title":"Outcome in juvenile onset systemic lupus erythematosus","volume":"17","author":"Ravelli","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pcl.2009.12.003_bib47","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/art.20412","article-title":"Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage","volume":"51","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","article-title":"Genetics of systemic lupus erythematosus: clinical implications","volume":"26","author":"Sullivan","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"10.1016\/j.pcl.2009.12.003_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/rheumatology\/keh693","article-title":"SLE \u2013 a disease of clearance deficiency?","volume":"44","author":"Munoz","year":"2005","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/rheumatology\/keh719","article-title":"Complement and its breakdown products in SLE","volume":"44","author":"Sturfelt","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.pcl.2009.12.003_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3083.2006.01808.x","article-title":"Regulatory T cells and systemic lupus erythematosus","volume":"64","author":"Mudd","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.pcl.2009.12.003_bib53","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25 (high) T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.pcl.2009.12.003_bib55","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/art.1780401210","article-title":"Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production","volume":"40","author":"Voll","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.pcl.2009.12.003_bib56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0961203307079036","article-title":"Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome","volume":"16","author":"Avcin","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.pcl.2009.12.003_bib58","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3476(80)80733-5","article-title":"The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood","volume":"96","author":"Lehman","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.pcl.2009.12.003_bib59","first-page":"1389","article-title":"The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus","volume":"15","author":"Shergy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2009.12.003_bib60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.56.4.272","article-title":"Anti-Ro\/SS-A and anti-La\/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus","volume":"56","author":"Oshiro","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pcl.2009.12.003_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J","article-title":"Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease","volume":"42","author":"Reichlin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780390420","article-title":"Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis","volume":"39","author":"Press","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.pcl.2009.12.003_bib63","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1182\/blood-2005-05-2048","article-title":"Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus","volume":"106","author":"Male","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.pcl.2009.12.003_bib64","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib65","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/0961203307078068","article-title":"Making the diagnosis of systemic lupus erythematosus in children and adolescents","volume":"16","author":"Tucker","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.pcl.2009.12.003_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00467-003-1278-y","article-title":"Lupus nephritis in childhood: a review of 53 patients followed at a single center","volume":"19","author":"Bogdanovic","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pcl.2009.12.003_bib67","first-page":"1537","article-title":"The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus","volume":"29","author":"Sibbitt","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ncprheum0988","article-title":"Neurocognitive impairment in children and adolescents with systemic lupus erythematosus","volume":"5","author":"Levy","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ncprheum0789","article-title":"Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus","volume":"4","author":"Sandborg","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib70","first-page":"203","article-title":"Pulmonary involvement in patients with childhood-onset systemic lupus erythematosus","volume":"24","author":"Lilleby","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pcl.2009.12.003_bib71","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","article-title":"Damage in systemic lupus erythematosus and its association with corticosteroids","volume":"43","author":"Zonana-Nacach","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib73","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2009.12.003_bib74","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","article-title":"Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial","volume":"125","author":"Gourley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2003.10.012","article-title":"Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials","volume":"43","author":"Flanc","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pcl.2009.12.003_bib76","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pcl.2009.12.003_bib77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1523-1755.2000.00832.x","article-title":"Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide","volume":"57","author":"Ioannidis","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcl.2009.12.003_bib78","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.20364","article-title":"Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis","volume":"50","author":"Mok","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib79","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis, the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib80","doi-asserted-by":"crossref","first-page":"R182","DOI":"10.1186\/ar2093","article-title":"Systematic review and meta-analysis of randomized trials and cohort studies of mycophenolate mofetil in lupus nephritis","volume":"8","author":"Moore","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib81","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Aspreva Lupus Management Study Group. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pcl.2009.12.003_bib82","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/art.20592","article-title":"Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus","volume":"50","author":"Anolik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib83","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib84","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib85","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.21650","article-title":"Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse","volume":"54","author":"Cambridge","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib87","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of TNF \u03b1- blockade in systemic lupus erythematosus \u2013 an open label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib88","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib89","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"issue":"16","key":"10.1016\/j.pcl.2009.12.003_bib90","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib91","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Hong Kong Nephrology Study Group. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.pcl.2009.12.003_bib92","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib93","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2002.003574","article-title":"EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis","volume":"63","author":"Yee","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1191\/0961203304lu1067sr","article-title":"Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus","volume":"13","author":"Tam","year":"2004","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib96","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.pcl.2009.12.003_bib97","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib98","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1797.2005.00444.x","article-title":"Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis","volume":"10","author":"Ong","year":"2005","journal-title":"Nephrology (Carlton)"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib99","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.21358","article-title":"Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus","volume":"52","author":"Bezerra","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.ki.5001630","article-title":"Dutch Working Party on Systemic Lupus Erythematosus. Azathioprine\/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial","volume":"70","author":"Grootscholten","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib101","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/art.22449","article-title":"Dutch Working Party on Systemic Lupus Erythematosus. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis","volume":"56","author":"Grootscholten","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pcl.2009.12.003_bib102","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/art.22198","article-title":"The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial","volume":"54","author":"Tseng","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib103","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2215\/CJN.02271205","article-title":"A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years","volume":"1","author":"Moroni","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.pcl.2009.12.003_bib104","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0961203307081340","article-title":"Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide","volume":"16","author":"Wang","year":"2007","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.pcl.2009.12.003_bib105","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/art.24068","article-title":"Canadian Network For Improved Outcomes in Systemic Lupus. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial","volume":"59","author":"Fortin","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib106","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/art.23673","article-title":"LJP 394-90-09 Investigator Consortium. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial","volume":"58","author":"Cardiel","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib107","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib108","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","article-title":"European Group for Blood and Marrow Transplantation; European League Against Rheumatism Registry. Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib109","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(200103)44:3<728::AID-ANR123>3.0.CO;2-D","article-title":"Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus","volume":"44","author":"Wulffraat","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2009.12.003_bib111","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10067-004-1065-6","article-title":"Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus","volume":"24","author":"Chen","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2009.12.003_bib112","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.pcl.2009.12.003_bib113","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (TReg) subsets return in patients with refractory lupus following adult stem cell transplantation: TGF-\u03b2 producing CD8+ Treg (CD8TGF-\u03b2 Treg) are associated with suppressing lupus into immunologic remission","volume":"183","author":"Zhang","year":"2009","journal-title":"J immunol"},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib114","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","article-title":"Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study","volume":"8","author":"Burt","year":"2009","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1016\/j.pcl.2009.12.003_bib116","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.pcl.2009.12.003_bib117","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pcl.2009.12.003_bib118","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2337\/diabetes.51.12.3353","article-title":"The risk of childhood type 1 diabetes in the 20th century","volume":"51","author":"Gale","year":"2002","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2009.12.003_bib119","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/diabetes.54.suppl_2.S125","article-title":"Environmental triggers and determinants of \u03b2-cell autoimmunity and type 1 diabetes","volume":"54","author":"Knip","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2009.12.003_bib120","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI14257","article-title":"Autoimmune type 1 diabetes: resolved and unresolved issues","volume":"108","author":"Notkins","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcl.2009.12.003_bib121","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1520-7560(199905\/06)15:3<205::AID-DMRR29>3.0.CO;2-O","article-title":"Quality of life and diabetes","volume":"15","author":"Rubin","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.pcl.2009.12.003_bib123","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib124","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2009.02.019","article-title":"Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus","volume":"8","author":"Tsirogianni","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.pcl.2009.12.003_bib125","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.4049\/jimmunol.0803348","article-title":"Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis","volume":"182","author":"Shehadeh","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pcl.2009.12.003_bib126","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/diab.43.11.1304","article-title":"Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives","volume":"43","author":"Bingley","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2009.12.003_bib127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","article-title":"The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure","volume":"46","author":"Roep","year":"2003","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.pcl.2009.12.003_bib128","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis","volume":"51","author":"Jeitler","year":"2008","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":"Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2009.12.003_bib130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus, The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2009.12.003_bib131","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4158\/EP.12.S1.34","article-title":"Insights from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes","volume":"12","author":"Genuth","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pcl.2009.12.003_bib132","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"DCCT. The Diabetes Control and Complications Trial Research Group The Effect of Intensive. Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin- Dependent Diabetes Mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib133","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MED.0b013e32807f2ac8","article-title":"Pancreas and islet transplantation in diabetes","volume":"14","author":"Pavlakis","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pcl.2009.12.003_bib134","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2337\/diacare.29.04.06.dc06-9908","article-title":"Pancreas and islet transplantation in type 1 diabetes","volume":"29","author":"American Diabetes Association","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcl.2009.12.003_bib136","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcl.2009.12.003_bib137","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-128-7-199804010-00001","article-title":"The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial","volume":"128","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib138","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(81)92761-6","article-title":"Partial preservation of pancreatic beta-cell function in children with diabetes","volume":"19","author":"Elliott","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2009.12.003_bib139","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2337\/diab.34.12.1306","article-title":"Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine","volume":"34","author":"Harrison","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2009.12.003_bib140","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diab.38.6.779","article-title":"Double-blind controlled trial of azathioprine in children with newly diagnosed type 1 diabetes","volume":"38","author":"Cook","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2009.12.003_bib141","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198809083191002","article-title":"Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus","volume":"319","author":"Silverstein","year":"1988","journal-title":"N Engl J Med"},{"issue":"8499","key":"10.1016\/j.pcl.2009.12.003_bib142","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(86)91943-4","article-title":"Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial","volume":"2","author":"Feutren","year":"1986","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.pcl.2009.12.003_bib143","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198803173181103","article-title":"Factors associated with early remission of type I diabetes in children treated with cyclosporine","volume":"318","author":"Bougneres","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib144","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.37.11.1574","article-title":"Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion","volume":"37","year":"1988","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.pcl.2009.12.003_bib145","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.25.7.1192","article-title":"Canadian-European Randomised Control Trial Group. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin","volume":"25","author":"Christie","year":"2002","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.pcl.2009.12.003_bib146","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00403182","article-title":"Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects","volume":"34","author":"Martin","year":"1991","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pcl.2009.12.003_bib147","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/diab.39.7.768","article-title":"Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin","volume":"39","author":"Assan","year":"1990","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diab.45.1.101","article-title":"Long-term results of early cyclosporin therapy in juvenile IDDM","volume":"45","author":"De Filippo","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2009.12.003_bib149","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib150","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2009.12.003_bib151","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1900\/RDS.2004.1.80","article-title":"Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset","volume":"1","author":"Saudek","year":"2004","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.pcl.2009.12.003_bib152","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(01)06801-5","article-title":"Beta-cell function in newly-onset type 1 diabetes and immunomodulation with a heat shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial","volume":"358","author":"Raz","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcl.2009.12.003_bib153","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/dmrr.707","article-title":"Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials","volume":"23","author":"Schloot","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"18","key":"10.1016\/j.pcl.2009.12.003_bib154","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa0804328","article-title":"GAD treatment and insulin secretion in recent-onset type 1 diabetes","volume":"359","author":"Ludvigsson","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/clim.2000.4882","article-title":"A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus","volume":"96","author":"Buckingham","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pcl.2009.12.003_bib156","unstructured":"Milanetti F, Bucha J, Testori A, et\u00a0al. Autologous hematopoietic stem cell transplantation for systemic sclerosis. Curr Stem Cell Res Ther, in press."},{"issue":"1","key":"10.1016\/j.pcl.2009.12.003_bib157","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2009.12.003_bib158","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/bmt.2008.64","article-title":"Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives","volume":"41","author":"Rabusin","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2009.12.003_bib159","first-page":"A49","article-title":"Autologous stem cell transplantation for juvenile dermatomyositis [abstract]","volume":"86","author":"Samarasinghe","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pcl.2009.12.003_bib160","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/sj.bmt.1704514","article-title":"Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease","volume":"33","author":"Elhasid","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.pcl.2009.12.003_bib161","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/08916930802198345","article-title":"Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bulous skin diseases","volume":"41","author":"Marmont","year":"2008","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.pcl.2009.12.003_bib162","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/rheumatology\/40.11.1299","article-title":"Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype","volume":"40","author":"Wedderburn","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.pcl.2009.12.003_bib163","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2003-10-3617","article-title":"Autologous hematopoietic stem cell transplantation for severe\/refractory intestinal Behcet disease","volume":"103","author":"Rossi","year":"2004","journal-title":"Blood"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395509001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395509001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:22:25Z","timestamp":1758475345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395509001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0031395509001758"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2009.12.003","relation":{},"ISSN":["0031-3955"],"issn-type":[{"type":"print","value":"0031-3955"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2009.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}